HIV drug showdown: which regimen causes fewer side effects?

This study followed 215 people newly diagnosed with HIV in Hong Kong to see how often they developed non-AIDS conditions like high blood pressure, diabetes, bone thinning, and kidney problems. Participants were on different anti-retroviral regimens, and researchers compared the rates of these conditions between those taking integrase inhibitor-based drugs and those on other treatments. The goal was to understand which treatment might be safer in the long run.